|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$3,750
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$78,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$777,894
|
$388,947
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
|
ZIA BC 005708
|
$777,894
|
$311,157
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
$1,400
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
$12,419
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-07S1
|
$37,430
|
$374
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$15,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
VIRUS DISCOVERY AND CHARACTERIZATION IN LARGE-SCALE CANCER SEQUENCING DATA
|
5R01CA178383-02
|
$202,685
|
$66,886
|
DING, LI
|
WASHINGTON UNIVERSITY
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Ou
|
ZIA CP010126 - 00580
|
$39,863
|
$3,986
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Validating Technology To Optimize Antibody Affinity For Targeting Therapeutics
|
5R33CA177333-02
|
$375,008
|
$123,753
|
FEDERSPIEL, MARK
|
MAYO CLINIC ROCHESTER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$171,540
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-02
|
$700,000
|
$8,750
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
3U10CA180858-02S1
|
$100,000
|
$1,250
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-02
|
$1,192,600
|
$14,908
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIA BC 005673
|
$382,108
|
$38,211
|
Keefer, Larry
|
CCR (NCI)
|
|
Use and Comparative Effectiveness of Innovative Therapies for Hepatocellular Carc
|
5K07CA160722-05
|
$170,100
|
$170,100
|
SANOFF, HANNA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
$1,875
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
$1,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$186,935
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urban Health Study
|
ZIA CP005782 - 10067
|
$174,551
|
$174,551
|
O'Brien, Thomas
|
DCEG (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$7,938
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$243,905
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$11,867
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$3,749
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$2,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$6,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$46,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S1
|
$114,745
|
$18,359
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S3
|
$177,700
|
$28,432
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-16
|
$1,361,692
|
$217,871
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S5
|
$1,213,480
|
$12,135
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S6
|
$48,256
|
$483
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Uncover the mechanisms regulating the biogenesis and decay of miRNAs in cancer
|
ZIA BC 011566
|
$925,596
|
$92,560
|
Gu, Shuo
|
CCR (NCI)
|
|
UCDCCC NCTN U10 Program
|
3U10CA180846-02S1
|
$99,708
|
$2,493
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-02
|
$630,226
|
$15,756
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor Suppressor Roles of E2F7 & E2F8 in Hepatocellular Carcinoma (HCC)
|
5R01CA121275-07
|
$331,382
|
$331,382
|
LEONE, GUSTAVO
|
OHIO STATE UNIVERSITY
|
|
Tumor models for the study of inflammation and oncogenesis
|
ZIA BC 010893
|
$283,350
|
$283,350
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Tumor Embolization Using A Novel Catheter With Integrated Flow Regulation
|
1R43CA192428-01A1
|
$221,873
|
$221,873
|
ALLEN, MICHAEL
|
EMBOLX, INC.
|
|
Tumor antigen-specific T-cells and hepatocellular carcinoma
|
5R01CA166111-03
|
$332,000
|
$332,000
|
KAPLAN, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-02
|
$315,400
|
$315,400
|
HORUZSKO, ANATOLIJ
|
GEORGIA REGENTS UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-16
|
$2,807,751
|
$224,620
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Training In Tumor Virology
|
5T32CA115299-10
|
$342,954
|
$68,591
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
TOR signaling and autophagy in obesity-promoted liver tumorigenesis
|
5R01CA155120-05
|
$351,277
|
$351,277
|
KARIN, MICHAEL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
TLR4 in obesity-driven liver cancer
|
5K22CA178098-03
|
$130,399
|
$130,399
|
CAVIGLIA, JORGE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Tissue Homeostatic Control by CSF-dependent Macrophage-Stromal Cell Interactions
|
5F30CA186626-02
|
$48,120
|
$24,060
|
JACOX, JEREMY
|
YALE UNIVERSITY
|
Total relevant funding to Liver Cancer for this search: $70,286,751
|